Promising Drug Targets and Compounds with Anti-<i>Toxoplasma gondii</i> Activity
Toxoplasmosis is a parasitic disease caused by the globally distributed protozoan parasite <i>Toxoplasma gondii</i>, which infects around one-third of the world population. This disease may result in serious complications for fetuses, newborns, and immunocompromised individuals. Current...
Main Authors: | Marco da Silva, Cátia Teixeira, Paula Gomes, Margarida Borges |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Microorganisms |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-2607/9/9/1960 |
Similar Items
-
Drug Repurposing Based on Protozoan Proteome: In Vitro Evaluation of In Silico Screened Compounds against <i>Toxoplasma gondii</i>
by: Débora Chaves Cajazeiro, et al.
Published: (2022-08-01) -
In Vitro and In Vivo Activities of Tilmicosin and Acetylisovaleryltylosin Tartrate against <i>Toxoplasma gondii</i>
by: Yazhen Ma, et al.
Published: (2022-08-01) -
Evaluating the Antiparasitic Activity of Novel BPZ Derivatives Against <i>Toxoplasma gondii</i>
by: Olivia Hatton, et al.
Published: (2020-07-01) -
<i>Toxoplasma gondii</i> in Foods: Prevalence, Control, and Safety
by: Pablo-Jesús Marín-García, et al.
Published: (2022-08-01) -
Seroprevalence of <i>Toxoplasma gondii</i> in Slaughtered Pigs in Kiambu, Kenya
by: Dorcas Chepyatich, et al.
Published: (2023-10-01)